Please note this' Sarepta has more info on it''s drug for dmd than anyone could ask for.this statement
seems dumb founded .
March 5, 2013
09:40 EDT SRPT Sarepta may not have enough eteplirsen data to satisfy FDA, says Summer Street
Summer Street said a former FDA employee expressed the opinion that Sarepta may be asked by the FDA to run a larger trial or trials of its experimental Duchenne Muscular Dystrophy treatment before the drug would be considered for approval.